SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 20th, 2019 • Aeterna Zentaris Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of September 20, 2019, between Aeterna Zentaris Inc., a corporation incorporated under the laws of Canada (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
Michael V. Ward President and Chief Executive Officer Aeterna Zentaris Inc.Placement Agent Agreement • September 20th, 2019 • Aeterna Zentaris Inc. • Pharmaceutical preparations • New York
COMMON SHARE PURCHASE WARRANT AETERNA ZENTARIS INC.Securities Agreement • September 20th, 2019 • Aeterna Zentaris Inc. • Pharmaceutical preparations
THIS COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after March [ ], 2020 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on [ ](1) (the “Termination Date”) but not thereafter, to subscribe for and purchase from Aeterna Zentaris Inc., a Canadian corporation (the “Company”), up to common shares (as subject to adjustment hereunder, the “Warrant Shares”) in the capital of the Company. The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
